Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2018 to date.

 
 
United States

2Morrow

 
 
United States

3E Bioventures

 
 
United Kingdom

4BIO Capital

 
 
United States

7wire Ventures

 
Sweden

A1M Pharma AB

 
United States

A6 Pharmaceuticals

 
United States

Aadi

 
United States

Aagami, Inc.

 
 
United States

Aberdeen Investment Management / NexTech Medical Ventures

 
Austria

ABF Pharmaceutical Services

Biotechnology - Therapeutics and Diagnostics

 
United States

ABGENOMICS INTERNATIONAL INC.

Biotechnology - Therapeutics and Diagnostics

 
Korea, South

ABL Bio Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Above and Beyond NB LLC

 
 
Sweden

Acarix AB

 
 
Canada

Acasti Pharma

 
Canada

Accelera Canada

 
 
United States

Accelerator Corporation

 
 
United States

Accelerator Fund

 
 
United States

Acer Therapeutics Inc.

 
 
United States

Aceras Life Sciences LLC

 
 
United States

Aceras Partners

Investor

 
 
United States

Achelois Oncology

 
France

Acticor Biotech

 
 
United States

Actinium Pharmaceuticals

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Acucela, Inc.

 
 
Australia

AdAlta Limited

Biotechnology - Therapeutics and Diagnostics

 
 
Spain

Adan Medical Innovation

Medical Technology

 
United States

Adepthera

 
United States

Adesis, Inc.

Supplier & Engineering

 
China

Adlai Nortye Biopharma CO., LTD.

 
Spain

ADVANCED MARKER DISCOVERY

 
 
China

Advantech Capital

 
 
United States

Aegis Capital Corp.

 
 
United States

Aegle Therapeutics Corporation

Biotechnology - Therapeutics and Diagnostics

 
United States

Aevi Genomic Medicine, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Agent Capital

 
 
United States

Agenus

Biotechnology - Therapeutics and Diagnostics

 
 
United States

AgeX Therapeutics, Inc.

 
 
United States

Agile Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Agilent

 
United States

Agilvax, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
Netherlands

Aglaia BioMedical Ventures

 
 
United States

Agnovos

 
 
United States

Aisling Capital LLC

 
United States

Ajinomoto Althea, Inc

 
 
United States

Alacrita

Professional Services and Consulting

 
 
United Kingdom

Albion Capital LLP

 
United States

Albumedix

 
United States

alcami

 
 
United States

Aleph Capital LLC

 
 
United States

Alignment Ventures, LLC

 
 
United States

Allele Capital Partners

Investor

 
 
Sweden

Alligator Bioscience AB

Biotechnology - Therapeutics and Diagnostics

 
United States

Althea

 
 
United States

Altimmune, Inc.

 
 
United States

Altitude Life Science Ventures

 
 
Canada

AmorChem Financial

Investor

 
 
United States

AmpliPhi Biosciences Corporation

 
 
United States

AMRI

Biotechnology / R&D Services

 
United States

Anelixis Therapeutics, LLC

 
 
United States

angelMD

 
 
United States

Angels + Life.Sci Investors

 
Japan

AnGes, Inc.

 
United States

Angiex Inc

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Angle Plc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Anglo Scientific

 
 
Israel

Anima Biotech

Biotechnology - Therapeutics and Diagnostics

 
 
Denmark

Antag Therapeutics

 
Taiwan

AP Biosciences, Inc.

 
 
United States

Aperiomics, Inc.

Biotechnology / R&D Services

 
United Kingdom

Apex Healthcare Consulting Limited

Professional Services and Consulting

 
 
China

ApolloBio Corp.

Pharma

 
Switzerland

APR Applied Pharma Research sa

Pharma

 
 
United States

Aptose Biosciences Inc.

 
United Kingdom

APTUS CLINICAL LIMITED

 
United States

Aqua Partners LLC

Professional Services and Consulting

 
 
Italy

ARCADIA SGR

 
 
United States

Arch Therapeutics, Inc.

 
 
United States

ARCUS VENTURES

 
 
United States

Ardea Biosciences

 
 
United Kingdom

Arix Bioscience

Investor

 
 
United States

Arizona Tech Investors

 
 
United States

Armis Biopharma, Inc.

 
 
Netherlands

Arthrogen

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Arthurian Life Sciences

Investor

 
 
United States

Artiman Ventures

 
 
United States

Asahi Kasei

Investor

 
Germany

Ascendis Pharma

 
 
United States

Aspire Capital Partners, LLC

Investor

 
Japan

Astellas Pharma Inc.

 
United States

Asterias Biotherapeutics, Inc.

 
 
United States

AstraZeneca

Pharma

 
 
United States

ATEM Capital

 
 
United States

Atentiv

 
 
Germany

Atriva Therapeutics GmbH

Biotechnology - Therapeutics and Diagnostics

 
Sweden

Atrogi AB

 
 
United Kingdom

Auspherix

 
 
United Kingdom

Autifony Therapeutics Ltd

 
 
United Kingdom

Avacta Group plc

Biotechnology - Therapeutics and Diagnostics

 
United States

Avaliv Therapeutics, Inc.,

 
 
Ireland

Avectas Ltd

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Avery Therapeutics, Inc.

 
United States

AVISA

Medical Technology

 
 
United States

AVM Biotechnology, LLC.

 
United States

AXIM Biotechnologies

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Axolotl Biologix, Inc.

 
 
United States

Axsome Therapeutics, Inc.

 
 
Germany

AYOXXA Biosystems GmbH

Biotechnology / R&D Services

 
 
United States

Aytu BioScience

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Azitra, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

AzurRx BioPharma, Inc.

Biotechnology - Therapeutics and Diagnostics

 
Switzerland

Bachem

 
 
United States

Bailard, Inc.

 
Australia

Baker McKenzie

 
 
United States

Band of Angels

 
 
United States

BAROnova, Inc.

Medical Technology

 
 
Switzerland

Bay City Capital

 
United States

Bay Strategies

 
United States

Bayer

 
United States

BBN Cardio Therapeutics

Pharma

 
 
Switzerland

BC Platforms

Biotechnology / R&D Services

 
 
Canada

BDC Healthcare Fund

 
United States

Be The Match

Biotechnology / R&D Services

 
 
United States

Bell Biosystems, Inc.

 
United States

Bellicum

 
 
Canada

BELLUS Health

Biotechnology - Therapeutics and Diagnostics

 
 
Australia

Benitec Biopharma Limited

 
 
Norway

BerGenBio ASA

 
United States

Berkley Life Sciences

 
 
United States

Bethesda Group Fund LLC

 
China

Betta Pharmaceuticals Co.,Ltd

Pharma

 
 
Japan

Beyond Next Venturs

Biotechnology - Therapeutics and Diagnostics

 
 
United States

BeyondSpring Pharmaceuticals

 
 
United States

BGI Venture

 
 
United States

Big Health Inc.

 
 
United States

Bio Ideations LLP

Investor

 
 
China

Bio-Thera Solutions

Biotechnology - Therapeutics and Diagnostics

 
 
United States

BioArdis

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Bioasis Technologies, Inc.

Biotechnology - Therapeutics and Diagnostics

 
United States

BioAxone BioSciences,Inc.

 
 
Australia

BioCapital Impact Fund

 
United States

BioCentury

 
 
Puerto Rico

Biocoast Capital

 
United States

Biocom

Public / Non-Profit Organizations

 
 
United States

BioEclipse Therapeutics

 
United States

BioFactura

 
 
United States

BioFuse Medical Technologies, Inc.

 
 
Netherlands

Biogeneration Ventures

Investor

 
 
United States

BioInnovation Capital

 
United States

Bioinvest-Medical Technology Stock Letter

 
Spain

Biokit Research & Development S.L.U.

 
 
Israel

BioLineRx

 
 
United States

BioMarker Strategies, LLC

 
 
Switzerland

BioMedPartners AG

 
 
Australia

Bionomics Ltd

Biotechnology - Therapeutics and Diagnostics

 
 
United States

BIOPACT VENTURES, LLC

 
United States

BioPharm Insight

 
United States

BioPharma Dive

 
France

BIOPHYTIS SA

Biotechnology - Therapeutics and Diagnostics

 
United States

BioQuest, A Diversified Search Co.

 
 
United States

Bios Partners

 
 
Australia

BioScience Managers

Investor

 
United States

Bioscript

 
 
United States

BioSense Global LLC

Biotechnology - Therapeutics and Diagnostics

 
 
United States

BioSig Technologies, Inc.

 
 
China

Biosion, Inc.,

Biotechnology - Therapeutics and Diagnostics

 
 
Israel

Biosphere Capital Ventures

 
 
Canada

BioSymetrics

 
 
United States

Biotech Alliances International INC

Investor

 
United States

Biotechpharma UAB/Northway Biotech, Inc.

 
United States

BioTime

Biotechnology - Therapeutics and Diagnostics

 
 
Australia

Biotron Limited

 
 
United States

Bioventures Investors

 
United States

BioVie Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
Switzerland

Biovotion

 
United States

BioWorld

 
France

BIOXIS Pharmaceuticals

Medical Technology

 
 
Germany

BK ValueS GmbH

Investor

 
 
United States

BL/SH Financial

 
 
United States

BlinkBio

 
 
United States

Body Vision Medical

 
 
China

BOHE Angel Fund

 
 
Netherlands

BOM Capital II B.V.

 
 
United States

Bond Bioscience

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Boson Capital Partners

 
 
France

Bpifrance

Investor

 
 
United States

Brace Pharma Capital

Investor

 
 
United States

Bradley Woods

 
United States

BrainStorm Cell Therapeutics Ltd.

 
 
United States

Brandon Capital Partners

 
United States

Bristol-Myers Squibb Company

 
 
United States

Broadview Ventures

 
 
United States

Brookline Capital Markets

 
United Kingdom

Brunel University

 
United Kingdom

BS Orphan

 
United States

Business France

Public / Non-Profit Organizations

 
 
China

BVCF

 
United States

Camargo Pharmaceutical Services

Professional Services and Consulting

 
Belgium

Camel-IDS NV

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Cantor Fitzgerald

 
United States

Capella Therapeutics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Capgenic Advisors

 
 
United States

Capital IP

Investor

 
Canada

Caprion Biosciences Inc.

 
France

Cardiawave SA

Medical Technology

 
 
Canada

Cardiol Therapeutics Inc.

 
 
United States

Carmell Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
Singapore

Carmentix Pte Ltd

Biotechnology - Therapeutics and Diagnostics

 
United States

CaroGen Corporation

Biotechnology - Therapeutics and Diagnostics

 
 
Taiwan

Cathay Venture Inc.

Investor

 
 
United States

Cato BioVentures

Investor

 
United States

CBIZ MHM

 
Japan

CDS

 
 
United States

Cedrus Investments

 
United Kingdom

Cell and Gene Therapy Catapult

 
 
United Kingdom

Cell Medica

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

CellAegis Devices Inc.

 
 
United States

Cellectar Biosciences

Biotechnology - Therapeutics and Diagnostics

 
United States

Cello Health Consulting

Professional Services and Consulting

 
 
United States

Cenna Biosciences Inc.

 
 
United States

Center for Neurologic Study

 
United States

CEPHEID

 
 
Switzerland

Cerbios-Pharma SA

Biotechnology / R&D Services

 
 
United States

Certara

 
 
United States

Cesca Therapeutics Inc.

Biotechnology - Therapeutics and Diagnostics

 
Australia

CharterNet

Professional Services and Consulting

 
United States

CheckOrphan

Media

 
 
United States

Checkpoint Therapeutics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Chembio Diagnostics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
Denmark

ChemPartner Europe

Biotechnology / R&D Services

 
 
United States

China Merchants Capital

 
United States

Choose New Jersey

 
 
United Kingdom

Chronos Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
Korea, South

Chungnam National University

 
United States

Cible

 
 
United States

CincyTech

 
 
United States

Cingulate Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Citius Pharmaceuticals, Inc.

Pharma

 
 
United States

Claremont Creek Ventures

 
Canada

Clarivate Analytics

 
 
United States

ClearView Healthcare Partners

Professional Services and Consulting

 
Ghana

CLEMEO ENTERPRISE

 
France

Clevexel Pharma

 
United Kingdom

Clinical Accelerator

Biotechnology / R&D Services

 
United States

Clinical Network Services

 
United States

Close Concerns

 
 
United States

CMC Biologics

 
United Kingdom

CN Bio Innovations

 
 
United States

Cognoa

Medical Technology

 
 
United States

Colonial Technology Development Co.

Biotechnology - Therapeutics and Diagnostics

 
United States

Combined Therapeutics Inc

 
 
United States

Conatus Pharmaceuticals

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Connecticut Innovations, Inc.

 
United States

ConSynance Therapeutics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

ContraFect Corporation

Biotechnology - Therapeutics and Diagnostics

 
 
United States

ContraVir Pharmaceuticals

 
 
Canada

Cormark Securities Inc.

Investor

 
Australia

CoSec Consulting

Professional Services and Consulting

 
United States

Cote Orphan a QuintilesIMS Company.

 
United States

Covanos, Inc

 
 
China

Cowin Venture

 
United States

CPC Scientific Inc.

 
 
Netherlands

Cristal Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
China

Crosswave Management, inc.

 
United States

Cryoport

Supplier & Engineering

 
Korea, South

CrystalGenomics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
United States

CTI

 
 
Canada

CTI Life Sciences

 
 
United States

Cue Biopharma, Inc

 
 
United States

Cultivation Capital

 
 
United States

Cure Pharmaceutical

Pharma

 
United States

CureLab Oncology, Inc.

 
 
New Zealand

CuroNZ Ltd

 
 
United States

CV Sciences, Inc.

Pharma

 
 
United States

Cybernaut Investment

 
 
United States

Cyclacel Pharmaceuticals, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Cypralis Ltd

 
 
United States

Cyrus Biotechnology

 
 
United States

CytoSorbents Corporation

 
 
United States

CytRx Corporation

 
 
Taiwan

Daiwa Corporate Investment

 
Canada

Dalton Pharma Services

Biotechnology / R&D Services

 
United States

Dana-Farber Cancer Institute

 
 
United States

Danhua Capital

 
United States

DavosPharma

Professional Services and Consulting

 
 
United Kingdom

DeBere Group Limited

Investor

 
 
China

Decheng Capital

Investor

 
United States

Decoy Biosystems

 
 
United States

Defined Health

 
 
United States

DEFTA Partners

 
United States

DEL BioPharma

Biotechnology - Therapeutics and Diagnostics

 
United States

Demy-Colton

Professional Services and Consulting

 
Canada

Denovamed Inc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Dermala Inc.

 
 
United Kingdom

DESTINY PHARMA PLC

 
 
Sweden

Diamyd Medical

 
 
United States

Diffusion Pharmaceuticals

 
United States

Digital Therapeutics Alliance

 
 
United States

Discover Fund Management, LLLP

 
United States

Diversigen

Biotechnology / R&D Services

 
 
Sweden

DNB Markets

 
 
United States

Dorset Capital LLC

 
 
United States

DoubleRock LLC

 
United States

Drawbridge Health

Medical Technology

 
United States

Drexel University

 
United States

Drexel University - Office of Technology Commercialization

Public / Non-Profit Organizations

 
 
United States

DrugCendR Inc.

Biotechnology - Therapeutics and Diagnostics

 
United States

DSI

 
 
United States

Dthera Sciences

Medical Technology

 
 
United States

Dymicron

 
 
United States

Dynamk Capital

 
United Kingdom

e-Therapeutics plc

 
Japan

EA Pharma Co., Ltd.

Pharma

 
 
Germany

Earlybird Health-Tech Management GmbH & Co. KG

 
 
United States

Easton Capital/Gore Range CapitAl

 
Germany

EBD Group

Professional Services and Consulting

 
 
Switzerland

Eclosion2

 
United States

Ecstasy LLC

Biotechnology - Therapeutics and Diagnostics

 
Turkey

Eczacibasi Healthcare-Investments

Pharma

 
 
United States

Edgewood Management LLC

 
 
United States

Edison

 
 
France

Edmond de Rothschild Investment Partners

 
 
China

Efung Capital in Shenzhen, China

Investor

 
 
Puerto Rico

EGB Ventures

 
 
United States

Eiger BioPharmaceuticals, Inc.

 
 
China

Eight Roads

 
United States

Elanco

Biotechnology - Therapeutics and Diagnostics

 
United Kingdom

Elasmogen Ltd

 
 
Australia

Elastagen Pty Ltd

 
 
United States

Eleven Biotherapeutics Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Eleven Two Capital

 
United States

Elex Biotech

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Embera NeuroTherapeutics, Inc.

Pharma

 
United States

EMD Serono

 
 
United States

Emerald Health Pharmaceuticals

Biotechnology - Therapeutics and Diagnostics

 
United States

Emergent BioSolutions

 
 
Canada

Emovi inc.

 
United Kingdom

Endomag

 
 
United Kingdom

Endomagnetics Ltd

Medical Technology

 
United States

Engine Room

Professional Services and Consulting

 
United States

Enplas America, Inc.

Supplier & Engineering

 
United States

Enteris BioPharma

Biotechnology - other

 
 
Australia

EpiAxis Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

Epic Capital Management

 
 
United Kingdom

Epidarex Capital Management LLP

Investor

 
 
United States

Epitracker, Inc.

 
United States

EpiVax

 
United Kingdom

Ergomed PLC

Pharma

 
 
Singapore

Esco Ventures Pte Ltd

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Esperante

Investor

 
United States

Espero BioPharma

Pharma

 
 
Belgium

etherna

 
 
United States

Eureka Therapeutics

 
Korea, South

Eutilex Co.,Ltd.

Biotechnology - Therapeutics and Diagnostics

 
United States

Evidation Health

 
United Kingdom

Evolution

 
 
United States

Exactus, Inc.

Medical Technology

 
 
United States

Excision BioTherapeutics Inc

 
 
United States

EXICURE, INC.

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Exscientia Ltd

 
 
United States

EXXclaim Capital

 
 
Switzerland

F. Hoffmann-La Roche Ltd.

 
 
China

Fangsheng Pharmaceutical

Investor

 
United States

Fannin Innovation Studio

 
 
Hungary

FastVentures

 
 
Denmark

FBC Device Aps

 
Canada

Feldan Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Femeda Ltd

 
 
United States

FenoLogica Biosciences, Inc.

 
United States

Ferghana Partners

 
United States

Ferring

Pharma

 
 
Germany

FGK Clinical Research GmbH

Biotechnology / R&D Services

 
 
Brazil

Fin Health Private Equity and Venture Capital

 
United States

Finney Capital

 
 
United States

First Analysis

 
United States

Flatley Discovery Lab

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Foley Hoag LLP

 
 
Canada

Fonds de solidarité FTQ

 
 
Netherlands

Forbion

 
Finland

Forendo Pharma

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Formation8 Partners

 
 
Ireland

Fountain Healthcare Partners

 
 
United States

FoxHill Asset Management

 
United States

FreeMind Group

Professional Services and Consulting

 
 
United States

Fresenius Medical Care Ventures GmbH

 
 
United States

Frontida BioPharm, Inc.

 
 
Belgium

Fund+

Investor

 
 
Germany

GAIA AG

 
France

GAMAMABS PHARMA

 
 
United States

GC Finance

 
 
United States

gel-e, Inc.

Medical Technology

 
Korea, South

GemVax & KAEL

Pharma

 
 
United States

Genetesis LLC

 
United States

Genisphere

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Genome Profiling (GenPro)

Biotechnology - Therapeutics and Diagnostics

 
 
Australia

Genome.One

 
United States

Genosco

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Genprex

 
United States

GeoVax Labs, Inc.

Biotechnology - Therapeutics and Diagnostics

 
Russian Federation

Gero

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Gila Therapeutics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
Australia

Gilt Edged Securities Pty Limited ACN 008 609 345

 
 
Germany

GIMV

 
 
United States

GIS Strategic Investors

 
Canada

GL CHEMTEC INTERNATIONAL LTD.

Biotechnology / R&D Services

 
Switzerland

Glenmark Pharmaceuticals SA

Pharma

 
Canada

Global Connectworks Ltd.

Professional Services and Consulting

 
United States

GlobalData

Professional Services and Consulting

 
United States

GlobalReach Business Solutions

Professional Services and Consulting

 
United States

Glycan Biosciences

 
Taiwan

GlycoNex Inc.

 
Netherlands

Glycostem

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Glynn Capital Management

 
 
Canada

Glysantis Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
Switzerland

GOGOL ASSOCIATES

 
 
United States

Golden Seeds

 
 
United States

GPG Ventures

Investor

 
 
United States

GRA Venture Fund

 
 
United States

Gray Strategic Advisors, LLC

 
 
United States

GrayBella Capital

 
 
United States

Great Point Partners

Investor

 
Korea, South

Green Cross Corporation

 
 
United States

Green Park & Golf Ventures

 
 
Italy

GREENBONE ORTHO SRL

 
United States

GreenField Chemical, Inc.

 
Australia

GreenLight Clinical

Biotechnology / R&D Services

 
 
Canada

GreenSky Capital

Investor

 
 
United States

Grey Sky Venture Partners

Investor

 
 
United States

griffin advisors

 
United States

Grifols

Pharma

 
United States

groupH

 
 
United States

GSR Ventures

 
France

GUSTAVE ROUSSY TRANSFERT

 
United States

GVK BIO

Biotechnology / R&D Services

 
France

H-IMMUNE

Biotechnology - Therapeutics and Diagnostics

 
 
United States

H.C. Wainwright & Co.

Professional Services and Consulting

 
Sweden

Hansa Medical AB

 
United Kingdom

Haoma Medica Ltd

 
United States

HDL Apomics

Biotechnology - Therapeutics and Diagnostics

 
 
Japan

HEALIOS K.K.

Biotechnology - Therapeutics and Diagnostics

 
 
Taiwan

Health Ever Bio-Tech Co., Ltd.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

HeartSciences, Inc

 
 
United States

Heat Biologics

 
 
United States

HEDA Ventures

 
 
Canada

Helix BioPharma Corp

 
United States

Helsinn (U.S) Therapeutics

Pharma

 
 
United States

Hemi Ventures

 
 
United States

Hemispherx Biopharma, Inc.

 
Finland

Herantis Pharma plc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Hercules Capital

Investor

 
 
Monaco

Hestia Investments Ltd.

Investor

 
 
Japan

Hikari Power

 
 
United States

Hillstream BioPharma Inc.

 
 
China

HitGen LTD.

Biotechnology - Therapeutics and Diagnostics

 
United States

HLTH

 
 
United States

Horizon Technology Finance

 
 
United States

HOST Therabiomics Ltd.

 
 
United States

Housey Pharma, LLC

 
 
Japan

HOYA

Medical Technology

 
Germany

Hummingbird Diagnostics GmbH

 
 
United Kingdom

IAG

 
France

ICOSA

 
United States

ICR

 
Korea, South

Ie Sung International

Professional Services and Consulting

 
United Kingdom

Illingworth Research Group

Pharma

 
 
United States

Illumina Ventures

Investor

 
 
United States

IM Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
Singapore

IMB/ ASTAR

Public / Non-Profit Organizations

 
Belgium

Imcyse S.A.

 
Canada

Imeka

 
Korea, South

IMGT

Pharma

 
Canada

Immune Biosolutions

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Immune Pharmaceuticals Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
Sweden

Immunicum AB

Biotechnology - Therapeutics and Diagnostics

 
United States

ImmunoMet Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

Immunovaccine Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Immusoft

 
 
Australia

Imugene, Limited

 
United States

INanoBio Inc

 
United States

INC Research/inVentiv Health

Professional Services and Consulting

 
Italy

Indena SpA

 
 
United States

Individual Investor - Wei Zhang

 
United States

Indus Tech Reports

 
 
Sweden

Industrifonden

 
United States

Informa-Medtrack

 
 
United States

Inivata, Inc.

 
 
Netherlands

Inkef Capital BV

Investor

 
United States

INmune Bio

 
Canada

Innodal Lab

 
 
United States

InnoSpring

 
 
United States

Innovation Pharmaceuticals Inc

 
 
United States

Innovation Ventures

 
United States

Innovators Club

 
France

Inotrem SA

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Inovio Pharmaceuticals

 
France

Inserm Transfert

 
Canada

InSymbiosis

 
 
United States

Integrated Resources Inc.

 
Israel

Integrity Applications

Medical Technology

 
 
Canada

IntelGenx

Biotechnology / R&D Services

 
Canada

Intellipharmaceutics

Biotechnology - other

 
 
Canada

Interface Biologics

 
Netherlands

InteRNA Technologies B.V.

 
 
United Kingdom

International Biotechnology Trust Plc

 
United States

International Milk Bank

Biotechnology - other

 
 
United States

InterWest Healthcare Partners

 
 
Switzerland

Inthera Bioscience AG

 
United Kingdom

Intract Pharma Ltd

Pharma

 
Canada

Intrinsik Corp.

Professional Services and Consulting

 
Canada

Inversago

Biotechnology - Therapeutics and Diagnostics

 
United Kingdom

Invicro

 
 
United Kingdom

Invisio Pharmaceuticals

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Invitrx Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
United States

InvVax, Inc.

 
 
United States

Iota Biosciences, Inc.

 
 
Luxembourg

IPF Management S.A. (referred to as IPF Partners)

 
France

Ipsen Pharma

Pharma

 
 
United States

IPV Capital

 
Canada

Iricor

 
Sweden

IRLAB Therapeutices

 
 
Netherlands

ISA Pharmaceuticals BV

 
 
United States

iSeed Ventures, LLC

Investor

 
 
Sweden

Isofol Medical AB

 
Germany

ITM Isotopen Technologien München AG

Pharma

 
United States

Ixchel Pharma

Biotechnology - Therapeutics and Diagnostics

 
 
Japan

JAFCO Co., Ltd.

Investor

 
 
United States

JDRF

 
United States

Jefferson Health Network

 
United States

JK BioPharma Solutions, Inc

 
Canada

JRF GOBAL

 
United States

JT Pharma

Pharma

 
 
United States

Julz Co

Investor

 
 
United Kingdom

Jupiter Diagnostics Limited

Medical Technology

 
 
United Kingdom

Juvenescence Limited

 
Japan

Kaken Pharmaceutical

Pharma

 
 
United Kingdom

KaNDy Therapeutics

 
 
United States

Karmel Capital

 
 
Sweden

Karolinska Development AB

 
 
Australia

Kazia Therapeutics Limited

 
 
United States

Kerberos BioPharma, Inc.

Biotechnology - Therapeutics and Diagnostics

 
Canada

Ketogen Inc.

 
 
United States

KFE LLC

 
 
United States

Knoll Capital Management

 
United States

KO | Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC

 
United States

Kowa Research Institute

Pharma

 
 
United States

KTB Ventures

 
 
France

kurma partners

 
 
United States

L2 Capital

 
United States

LA BioMed

 
 
United States

Lakewood-Amedex

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Landmark Angels

 
 
United States

Landos Biopharma

Biotechnology - Therapeutics and Diagnostics

 
Canada

Laurent Pharmaceuticals

 
Australia

LBT Innovations

Medical Technology

 
 
United States

Leading BioSciences Inc

Biotechnology - Therapeutics and Diagnostics

 
United States

Leerink Partners

 
Korea, South

LegoChem Biosciences

 
United States

Levolta Pharmaceuticals

Pharma

 
Netherlands

Liberi Life Sciences Consultancy BV

Professional Services and Consulting

 
United States

Life Chemicals

 
 
United States

Life Science Angels

Investor

 
Japan

Life Science Innovation Network Japan, Inc.

Public / Non-Profit Organizations

 
United States

Life Science Washington

 
Australia

Life Sciences Queensland Limited

 
 
Netherlands

Life Sciences Research International BV

Professional Services and Consulting

 
 
United States

Life365

Medical Technology

 
 
United Kingdom

LifeArc

 
United States

Lifex Biolabs.com

Biotechnology - Therapeutics and Diagnostics

 
 
United States

LikeMinds, Inc

 
 
United States

Lin BioScience

 
 
United States

Lincoln Park Capital

Investor

 
Australia

Linear Clinical Research

Biotechnology / R&D Services

 
United States

Livzon Mabpharm USA

 
 
United States

Long River Ventures, SV Health Investors, Hub Angels Investment Group

 
United States

Lowenstein Sandler LLP

 
Australia

Luina Bio Pty Ltd

 
 
Canada

Lumira Capital

Investor

 
 
China

LYFE Capital

 
United States

Lynkogen Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

M Ventures

 
 
Germany

m2p-labs GmbH

Biotechnology / R&D Services

 
Sweden

Magle Chemoswed

 
 
United Kingdom

Malin Corporation Plc

 
 
Russian Federation

Management company RUSNANO LLC

Biotechnology - Therapeutics and Diagnostics

 
 
Austria

Marinomed Biotech AG

Pharma

 
Japan

Maruho Co., Ltd

 
 
United States

Mateon Therapeutics, Inc.

 
 
United States

MatriSys Bioscience, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

MaxCyte, Inc.

 
France

Mayoly Spindler

Pharma

 
 
Japan

MBL Venture Capital Co., Ltd.

 
United States

McDonnell Boehnen Hulbert & Berghoff LLP

Professional Services and Consulting

 
United States

MDNA Life Sciences

Biotechnology - Therapeutics and Diagnostics

 
Canada

Med-Life Discoveries

 
United States

MedCity News

 
France

MedDay Pharmaceuticals

Pharma

 
Canada

Medicenna Therapeutics Corp.

Biotechnology - Therapeutics and Diagnostics

 
United States

Medicines360

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Medigram

 
United States

MedImmune

 
 
United States

Mediqventures

 
 
United States

Medmarc Insurance Group

Professional Services and Consulting

 
 
United States

MedPro Investors LLC

 
United States

MedSource

 
United States

Meissa Vaccines

 
 
France

Mensia Technologies SA

 
 
United States

Merck

 
 
Netherlands

Merck Ventures BV

 
United States

Meridian Clinical Research

 
 
United States

Meru Health Inc.

 
 
United States

Mesa Verde Venture Partners

 
France

Metafora Biosystems

 
 
United States

Metastat, Inc.

 
 
Switzerland

Metys Pharmaceuticals

 
 
United States

MFB Fertility, Inc.

 
 
United States

MIDTOWN PARTNERS LLC

 
 
China

Milestone Capital

Investor

 
 
United States

Militia Hill Ventures

Investor

 
United States

Millendo Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Millhouse LLC

 
United States

MILLIMAN

Professional Services and Consulting

 
Germany

Miltenyi Biotec

Biotechnology - Therapeutics and Diagnostics

 
France

Minakem

 
United Kingdom

Mironid

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Mirsona, Inc.

 
 
United States

Mitsui & Co. Global Investment, Inc

Investor

 
 
Sweden

Modus Therapeutics AB

 
 
United Kingdom

Momentum Biotech

 
United States

MonoSol Rx

Pharma

 
 
United States

Montrose Capital Partners

 
United Kingdom

Morgan Prestwich

 
 
United States

MP Healthcare Venture Management, Inc.

Investor

 
Canada

MPeria Therapeutics Inc

 
 
United States

MPM Capital

Biotechnology - Therapeutics and Diagnostics

 
 
United States

MVP Capital Partners

 
Canada

My Intelligent Machines

 
United States

myTomorrows

 
 
United States

NanoBio Corporation

 
 
United States

NanOlogy

Pharma

 
United States

NanoValent Pharmaceuticals Inc.

 
 
United States

NanoViricides, Incorporated

 
Taiwan

National Cheng- Kung University

 
United States

National Institutes of Health/National Institute on Aging

 
 
United States

Navidea Biopharmaceuticals

 
 
United States

Navigen

 
Sweden

NDA Group

Professional Services and Consulting

 
 
United States

NeoLight

 
 
United Kingdom

NeRRe Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
Australia

NeuClone

Biotechnology - Therapeutics and Diagnostics

 
 
United States

NeuroActiva, Inc.

Biotechnology - Therapeutics and Diagnostics

 
United States

Neurocrine Biosciences

 
United States

Neurocycle Therapeutics

 
 
United States

NeuroMetrix, Inc.

 
 
United States

Neuroparticle Corporation

Medical Technology

 
 
United States

NeuroRx, Inc.

 
Israel

Neurosteer

 
 
United States

Neurotrope Bioscience

 
Sweden

NeuroVive Pharmaceutical AB

Biotechnology - Therapeutics and Diagnostics

 
United States

New York City Economic Development Corporation

 
 
Finland

Nexstim Plc

Medical Technology

 
 
Australia

Next Science

Medical Technology

 
 
United States

Nexus Life Science Partners

 
 
France

NH THERAGUIX

 
 
Korea, South

NHN Investment

 
United States

NI Research

 
Switzerland

NLS Pharma Group

 
 
United States

Nokia Growth Partners

 
Norway

Nordic Nanovector ASA

 
Germany

Nordmark Arzneimittel GmbH & Co. KG

 
France

Novadiscovery

Biotechnology / R&D Services

 
 
United States

Novellus

 
 
Denmark

Novo Holdings A/S

 
 
United States

Novo Nordisk

 
Australia

Novotech

 
 
United States

NSIP LLC

Investor

 
Canada

Nucro-Technics

 
United States

Numerate

 
Canada

Nuvo

 
 
United States

NuvOx Pharma

 
 
United Kingdom

O2h Ventures Limited

 
Canada

OB Pharmaceuticals, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Oceaniq Capital Partners

 
Belgium

OCTIMET Oncology NV

 
 
United States

Olatec Therapeutics LLC

Biotechnology - Therapeutics and Diagnostics

 
Korea, South

OliPass Corporation

Biotechnology - Therapeutics and Diagnostics

 
France

OLMIX GROUP

Biotechnology - Therapeutics and Diagnostics

 
United States

Ology Bioservices

Biotechnology / R&D Services

 
United States

Omada Health, Inc.

Medical Technology

 
 
United States

Onconova Therapeutics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

OncoResponse, Inc.

 
 
United States

OncoSec Medical Incorporated

 
 
Germany

Oncotec

Pharma

 
 
Australia

Ondek Pty Ltd

 
 
Switzerland

Onelife.ch

Investor

 
Canada

Ontario Government

 
United States

Openwater

 
United States

OPHTHOTECH

Biotechnology - Therapeutics and Diagnostics

 
United Kingdom

Oppilotech Ltd

 
 
Ireland

Opsona Therapeutics Ltd

Biotechnology - Therapeutics and Diagnostics

 
Germany

Optimapharm GmbH

 
 
United States

OrbiMed Advisors LLC

 
 
United States

Oresund Capital

 
 
United States

Orig3n

 
 
United States

Orpheus Therapeutics, Inc.

 
 
Australia

Orthocell Ltd

Medical Technology

 
Korea, South

Orum Therapeutics

 
 
France

OSE Immunotherapeutics

Biotechnology - Therapeutics and Diagnostics

 
United States

Otomagnetics

 
Japan

Otsuka Pharmaceutical Co., Ltd.

Pharma

 
 
Australia

Oventus Medical Ltd

 
 
Canada

Owen Barry Pharmaceuticals

 
 
United Kingdom

Oxford BioMedica (UK) Ltd

 
 
United Kingdom

Oxstem

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Oxygen Therapy Inc.

 
New Zealand

Pacific Edge Limited

Biotechnology - Therapeutics and Diagnostics

 
 
Hong Kong

Pacific GeneTech Limited

Biotechnology - other

 
Denmark

PanCryos

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

Pangaea Ventures

Investor

 
 
United States

Pappas Capital

 
United States

PAREXEL International

Biotechnology / R&D Services

 
 
United States

Partisan Management Group, Inc.

 
Canada

Partner International Inc.

Professional Services and Consulting

 
France

PATHOQUEST

 
 
United States

PBCTech

 
 
United States

PBM Capital Group

 
 
Norway

PCI Biotech

 
United States

Pear Therapeutics

 
 
Germany

Peppermint Venture Partners

 
 
United States

Peptilogics, Inc.

 
Sweden

PEPTONIC MEDICAL

 
 
United States

Peregrine Pharmaceuticals / Avid Bioservices

 
 
United States

Persephone Biome, Inc.

 
 
China

Phagelux, Inc.

 
 
Austria

PhagoMed Biopharma GmbH

 
 
Korea, South

PharmAbcine

 
United States

PharmaDirections

Professional Services and Consulting

 
 
France

Pharmaleads

Pharma

 
France

Pharnext

 
 
Australia

Phylogica

 
 
Canada

PI Financial

 
 
Israel

PillTracker, Ltd

 
United States

PIN Pharma, Inc.

Biotechnology - Therapeutics and Diagnostics

 
India

Piramal Pharma Solutions

 
 
United States

Pivotal BioVenture Partners

 
 
Israel

PixCell Medical

Biotechnology - Therapeutics and Diagnostics

 
United States

Platinum Research Network

Biotechnology / R&D Services

 
 
Israel

Pluristem Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Pneuma Respiratory, Inc

 
United Kingdom

Pneumagen Ltd

 
 
United States

PNP Therapeutics, Inc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

PoC Capital, LLC

 
 
United States

Poiesis Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
United States

Polaryx Therapeutics, Inc

Biotechnology - Therapeutics and Diagnostics

 
United States

PolyPeptide Group

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Portola Capital Partners

 
Canada

Precision Proteomics

 
 
Korea, South

Premier Partners, LLC

 
United States

PrEP Biopharm

 
 
Australia

Prescient Therapeutics Limited

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Pressure BioSciences, Inc.

 
Switzerland

PREXTON

 
Australia

Prime Financial Group

Professional Services and Consulting

 
United States

Primordial Genetics Inc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Progenitor Life Sciences

 
United Kingdom

Proimmune Ltd

 
United Kingdom

Prokarium

 
 
United States

ProLung, Inc.

Medical Technology

 
 
United States

ProMed Partners, LP

 
United States

ProPharma Group

Professional Services and Consulting

 
Switzerland

PROPONENT Biotech GmbH

 
 
United States

Proteus Venture Partners

 
 
United States

Protomer Technologies Inc.

 
 
United States

Proxenia Venture Partners

 
 
United States

pSivida Corporation

 
Canada

Pulse Infoframe Inc

Medical Technology

 
 
United States

Purdue Pharma L.P.

 
United States

Pyramid Biosciences, Inc

 
 
United States

QalibreMD, Inc.

 
Australia

QBIOTICS

Biotechnology - Therapeutics and Diagnostics

 
 
Hong Kong

Qiming Venture Partners

 
 
United States

QT Medical

 
 
France

Quantum Genomics

 
 
 
United States

Qventus

Medical Technology

 
 
Australia

Race Oncology Ltd

 
 
United States

RadImmune Therapeutics, Inc.

 
United States

Rapamycin Holdings, Inc.

Pharma

 
 
Russian Federation

RBV Capital

 
 
United States

Rebiotix Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Recursion Pharmaceuticals

 
 
Israel

RedHill Bioharma Ltd.

Pharma

 
United States

Reed Smith LLP

 
 
United States

Reed-Ventures

 
 
United States

Regenacy Pharmaceuticals LLC

 
 
United States

Regis Custom Pharma

Pharma

 
 
Canada

Relentless Pursuit Partners

 
 
Israel

REMEDOR BIOMED

Pharma

 
 
China

RemeGen LTD

 
France

Reminisciences

 
 
United Kingdom

ReNeuron Group plc

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

RepliCel Life Sciences, Inc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Resolys Bio, Inc.

 
 
United States

RespireRx Pharmaceuticals Inc.

 
 
Canada

Resverlogix Corp

 
 
United States

Rethink Impact

 
Canada

Retnia

Medical Technology

 
 
United Kingdom

ReViral Ltd

 
United States

Reviva Pharmaceuticals Inc

 
 
United States

Revon Systems

 
 
United States

Rexahn Pharmaceuticals, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

RFPi, Inc

 
Japan

RGF Executive

 
 
United States

RIFT Biotherapeutics

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

Rna Diagnostics Inc.

 
United States

Rodman Media

 
United States

RoosterBio, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Rosetta Capital Ltd

 
 
United States

Roswell Biotechnologies Inc.

 
 
Czech Republic

RSJ/Gradus

 
United States

RxCelerate

 
 
United States

RXi Pharmaceuticals Corporation

 
United States

Sabin Vaccine Institute

Public / Non-Profit Organizations

 
 
United States

Sacramento Angels

 
 
China

SAIF Partners

 
 
Switzerland

Salus Partners SA

 
Korea, South

Samsung BioLogics

 
 
United States

San Diego Tech Coast Angels

 
 
Canada

Sandman Financial Inc.

 
 
Denmark

Saniona AB

 
United States

Sanofi

 
 
Canada

SaNOtize Research and Development Corp.

 
Switzerland

Saphetor

 
United Kingdom

Sareum Ltd

 
 
United States

Savonix

 
United States

Scienion US Inc

 
Australia

Scientia Clinical Research

 
 
United States

Scotasian Capital

 
United States

Scottish Development International

Public / Non-Profit Organizations

 
United States

SDC

 
 
United States

SDL Ventures, LLC

 
 
United States

Sea Otter Global Ventures

 
 
Israel

Sebana Medical Ltd.

 
 
United States

Sense Diagnostics, LLC

 
Switzerland

Sensile Medical AG

Medical Technology

 
 
United States

SentiAR, Inc.

 
Canada

Sernova Corp

Biotechnology - Therapeutics and Diagnostics

 
France

SERVIER

 
 
France

Seventure

 
 
China

Shanghai Grand Financial Investment Co., LTD.

 
United States

Sharp Edge Labs

Biotechnology - Therapeutics and Diagnostics

 
 
China

Shenzhen Efung Investment Management Enterprise L.P.

 
 
Japan

Shinsei Corporate Investment Limited

Investor

 
 
Taiwan

SHL Group

Medical Technology

 
United States

Siamab Therapeutics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

Sierra Oncology

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Sigilon Therapeutics Inc

 
 
United States

Silicon Valley Bank

 
Switzerland

Sirius Healthcare Partners

Professional Services and Consulting

 
United States

Sirnaomics, Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

SLV

 
 
United States

SMART Brain Aging, Inc.

 
 
United States

Sonoran Biosciences, Inc

 
 
United States

Sophiris Bio Inc.

Biotechnology - Therapeutics and Diagnostics

 
 
Canada

Soricimed Biopharma Inc.

 
Japan

SOUSEIKAI Global Clinical Research Center

 
United States

Southern Research

Public / Non-Profit Organizations

 
Australia

Southern Star Research

 
 
Canada

SpecificiT Pharma Inc.

Biotechnology - Therapeutics and Diagnostics

 
Korea, South

ST PHARM

Pharma

 
United States

STAT

 
United States

State of Minnesota Department of Employment and Economic Development

 
United States

STATKING Clinical Services

 
 
United States

StemBioSys, Inc.

Biotechnology - other

 
Canada

Stiris Research

 
United States

Streetwise Reports

 
Japan

Sumitomo Dainippon Pharma

Pharma

 
 
United Kingdom

Summit Therapeutics plc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Sun Genomics

 
India

SUN PHARMA ADVANCED RESEARCH CO. LT

Pharma

 
United States

Sunovion Pharmaceuticals

 
 
Denmark

Sunstone Capital – Life Science Ventures

Investor

 
United States

SUSAVION BIOSCIENCES, INC.

Biotechnology - Therapeutics and Diagnostics

 
United States

Suven Neurosciences Inc

Pharma

 
 
United Kingdom

SV Health Managers LLP

 
United Kingdom

Sygnature Discovery

Biotechnology / R&D Services

 
United States

Sylva International

Professional Services and Consulting

 
 
United States

Symogen

Professional Services and Consulting

 
 
Netherlands

Synaffix BV

 
Switzerland

Synbias Pharma AG

 
Taiwan

SynCore Biotechnology Co., Ltd

 
Belgium

SYNGULON

 
 
United States

Syno Capital

 
United Kingdom

SYNthesis Research

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Synthetic Biologics

 
 
United States

Syzygy Therapeutics

 
 
United States

Tactics II Equity LLC

 
 
United States

Tactivia Therapeutics

 
Netherlands

Tadas Apgaule

 
 
Taiwan

TAHO Pharmaceuticals Ltd.

Pharma

 
 
Australia

Talu Ventures

 
United States

Tangen Biosciences, Inc.

Medical Technology

 
 
United States

TARA Biosystems

Biotechnology / R&D Services

 
United States

Target Health Inc.

Biotechnology / R&D Services

 
 
Australia

Tarnagulla Ventures

Investor

 
 
United States

Tarveda Therapeutics

 
 
United States

TAXIS Pharmaceuticals, Inc.

 
 
South Africa

TCD Group

 
 
United States

Tech Coast Angels, San Diego

 
Japan

Techno Network Shikoku Co. Ltd (Shikoku TLO)

 
 
United States

TEGA Therapeutics

Biotechnology - Therapeutics and Diagnostics

 
Japan

Teijin Pharma

Pharma

 
 
Canada

Teralys Capital

Investor

 
United States

Tergus Pharma

 
Canada

Tetra BioPharma

Biotechnology - Therapeutics and Diagnostics

 
United States

Teva Pharmaceuticals Inc.

 
United States

The Inspiracy

Professional Services and Consulting

 
United States

The Jackson Laboratory

Public / Non-Profit Organizations

 
Denmark

The Novo Nordisk Foundation Center for Biosustainability

 
United States

The Oxford Club

 
United States

Therakine, Inc

 
 
Israel

Therapix Biosciences

 
France

TheraVectys

 
United States

ThermoPharma

 
 
United States

Third Coast Therapeutics

 
Canada

Three Rivers Cardiovascular Systems

 
 
United States

Thrive Bioscience, Inc.

 
Belgium

ThromboGenics NV

 
 
Netherlands

thuja capital management

 
Japan

Thyas Co. Ltd.

Biotechnology - Therapeutics and Diagnostics

 
 
Spain

TiGenix

 
Sweden

TikoMed AB

 
Japan

Tokushima University/ Shikoku TLO

 
Japan

Tokyo Stock Exchange, Inc.

 
 
United States

Tonix Pharmaceuticals Holding Corp.

 
United States

Torreya

 
United States

Torreya Insights

Professional Services and Consulting

 
France

Torskal

Biotechnology - Therapeutics and Diagnostics

 
 
United Kingdom

Touchstone Innovations

 
Taiwan

TPG Biologics, Inc.

 
United Kingdom

Transcrip

Professional Services and Consulting

 
 
United States

Tremeau Pharmaceuticals

Biotechnology - Therapeutics and Diagnostics

 
United States

Trethera Corporation

 
 
United States

Triathlon Medical Ventures

 
United States

Trieza Therapeutics

 
 
United States

Trovagene, Inc.

 
 
China

Tsinghua Holdings Capital

 
United States

Tulane University

Public / Non-Profit Organizations

 
 
Hong Kong

TVM Capital China Limited

 
 
Germany

TVM Life Science Management

 
 
United States

Two Sigma Ventures

 
United States

twoXAR

Biotechnology - Therapeutics and Diagnostics

 
Israel

TyrNovo Ltd.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

Ultivue Inc.

 
Sweden

Umecrine Cognition AB

Biotechnology - Therapeutics and Diagnostics

 
United States

University City Science Center

 
United Kingdom

University of Edinburgh

Public / Non-Profit Organizations

 
Liberia

University of Liberia Department of Chemistry

 
 
United States

University Venture Fund II

Investor

 
 
United States

Univfy Inc,.

 
 
United States

Unum Capital

 
Philippines

UPLB

 
 
New Zealand

Upside Biotechnologies Ltd.

Biotechnology - Therapeutics and Diagnostics

 
 
United States

US Angels

 
 
Belgium

V-Bio Ventures

 
 
United States

V2M Capital

 
 
United States

Valley Fever Solutions

 
 
United States

Van Leeuwenhoeck Inc

Professional Services and Consulting

 
United States

Variant Pharmaceuticals

 
 
United States

Vaxess Technologies, Inc

Biotechnology - Therapeutics and Diagnostics

 
 
United States

VCapital

 
Norway

Vectron Biosolutions

Biotechnology / R&D Services

 
Germany

Ventaleon GmbH

 
 
 
Switzerland

Venture Valuation AG

 
 
United States

Ventureast

 
 
United States

Verseon Corporation

 
Germany

Vetter Pharma International GmbH

 
 
Switzerland

VI Partners